How Big Is the Intracranial Aneurysm Market?
According to 6Wresearch internal database and industry insights, the
Global intracranial aneurysm market was valued at USD 1.5 Billion in 2026 and is projected to reach approximately USD 2.2 Billion by 2032, expanding at a CAGR of 7.00% during the forecast period (2026–2032).
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global intracranial aneurysm market.
This growth is being bolstered by rising awareness about early neurological interventions, rising prevalence of brain aneurysms, and the growing adoption of minimally invasive endovascular coiling and flow-diverter procedures.
Key Growth Factors of the Intracranial Aneurysm Market
- Prevalent incidence of high blood pressure, smoking, and genetic predisposition contributing to aneurysm formation
- Rising awareness and availability of preventive screening and diagnosis
- Improvements in neuroimaging techniques such as CTA and MRA
- Surge in demand for non-invasive or minimally invasive treatment solutions
- Significant rise in global investments in neurology-focused healthcare infrastructure
- Increasing use of 3D-printed models for surgical planning and patient education
Intracranial Aneurysm Market Trends
Intracranial Aneurysm Market is experiencing growing traction for endovascular procedures such as coiling, stent-assisted coiling, and flow diversion. Artificial intelligence and machine learning are increasingly being incorporated for automated aneurysm detection in radiology. There is also a shift toward patient-specific treatment planning, supported by precision medicine approaches and wearable monitoring tools for post-treatment care.
Emerging Developments in the Intracranial Aneurysm Market
Intracranial Aneurysm Market is witnessing groundbreaking innovations such as biodegradable embolic devices, AI-powered early diagnosis systems, and robotics-assisted neurosurgery. Integration of augmented reality (AR) for pre-operative simulations and intra-operative guidance is gaining traction. Moreover, collaborative research between medical device companies and neurology institutes is boosting the development of next-generation aneurysm treatment platforms.
Leading Companies in the Intracranial Aneurysm Industry
- Stryker Corporation
- MicroVention Inc. (a Terumo company)
- Medtronic plc
- Phenox GmbH
- Johnson & Johnson (Cerenovus)
- Penumbra Inc.
- BALT Group
How big is the Intracranial Aneurysm Market : FAQ's
The market is driven by rising cases of brain aneurysms, increasing adoption of minimally invasive procedures, and advancements in neurovascular devices.
The intracranial aneurysm market is estimated to exceed USD 2.2 billion by 2031.
Prominent companies include Medtronic, MicroVention (Terumo), B. Braun, and Johnson & Johnson (Cerenovus).
Trends include increasing use of flow-diverting stents and growing emphasis on AI-based imaging technologies.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com